Department of Clinical Medicine, Sapienza University, Rome, Italy.
Eur J Pharmacol. 2011 Sep;668 Suppl 1:S87-90. doi: 10.1016/j.ejphar.2011.06.060. Epub 2011 Jul 27.
Anorexia and muscle wasting are frequently observed in cancer patients and influence their clinical outcome. The better understanding of the mechanisms underlying behavioral changes and altered metabolism yielded to the development of specialized nutritional support, which enhances utilization of provided calories and proteins by counteracting some of the metabolic derangements occurring during tumor growth. Inflammation appears to be a key factor determining the cancer-associated biochemical abnormalities eventually leading to anorexia and cachexia. Interestingly, inflammation is also involved in carcinogenesis, cancer progression and metastasis by impairing immune surveillance, among other mechanisms. Therefore, nutritional interventions aiming at modulating inflammation to restore nutritional status may also result in improved response to pharmacological anti-cancer therapies. Recent clinical data show that supplementation with nutrients targeting inflammation and immune system increases response rate and survival in cancer patients. This suggests that nutrition therapy should be considered as an important adjuvant strategy in the multidimensional approach to cancer patients.
厌食症和肌肉减少症在癌症患者中经常观察到,影响他们的临床结局。对行为改变和代谢改变的机制的更好理解导致了专门的营养支持的发展,该支持通过对抗肿瘤生长过程中发生的一些代谢紊乱来增强提供的卡路里和蛋白质的利用。炎症似乎是决定与癌症相关的生化异常最终导致厌食症和恶病质的关键因素。有趣的是,炎症还通过损害免疫监视等机制参与致癌作用、癌症进展和转移。因此,旨在调节炎症以恢复营养状态的营养干预也可能导致对癌症药物治疗的反应改善。最近的临床数据表明,用针对炎症和免疫系统的营养素进行补充可提高癌症患者的反应率和生存率。这表明营养疗法应被视为癌症患者多维治疗的重要辅助策略。